Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis

NCT05511519 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Psoriatic Arthritis

Interventions

DRUG: ATI-450
DRUG: Placebo Oral Tablet

Sponsor

Aclaris Therapeutics, Inc.